Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimify-M2 Tablet

Prescription Icon
Prescription Required

Marketer

Fidus Healthcare

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimify-M2 Tablet

Diabetic patients often utilize Dual-Action Diabetes Control tablets, a medication grouping classified as anti-diabetic agents. This dual-component formulation manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with seemingly controlled glucose levels; abrupt cessation risks elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, encompassing a balanced diet, physical activity, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and trembling. Maintain regular meals and carry a readily available fast-acting glucose source, like sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Individuals with a history of heart conditions should consult their physician before commencing treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Glimify-M2 Tablet

Managing type 2 diabetes

Major Benefits of Glimify-M2 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimify-M2 should be taken with a meal.

Common Side effects of Glimify-M2 Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimify-M2 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Glimify-M2 Tablet with a meal.

How Glimify-M2 Tablet works:

Glimify-M2 tablets contain glimepiride and metformin, two medications that manage blood sugar levels. Glimepiride, a sulfonylurea, stimulates the pancreas to produce more insulin, thus reducing blood glucose. Metformin, a biguanide, functions by decreasing liver glucose output, slowing intestinal glucose uptake, and enhancing the body's response to insulin.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Glimify-M2 Tablet and alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimify-M2 Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimify-M2 tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimify-M2 Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glimify-M2 Tablet use. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimify-M2 Tablets cautiously, potentially requiring dosage modification. Consult your physician. A low initial dose is typically prescribed for those with mild to moderate liver disease; however, it's contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimify-M2 Tablet :

Should you forget a Glimify-M2 Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimify-M2 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimify-M2 Tablet

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimify-M2 Tablet use can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimify-M2 immediately and seek immediate medical attention.
Glimify-M2 Tablet combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Glimify-M2 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glimify-M2 Tablet use can lead to Vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental Vitamin B12 is recommended at least annually, according to some research.
Glimify-M2 Tablets can cause low blood sugar (hypoglycemia), characterized by symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimify-M2 tablets and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Glimify-M2 Tablet
49
MRP 60
18% off